Elanco Animal Health Incorporated
DE ˙ DB ˙ US28414H1032
20,80 € ↑0,04 (0,19%)
2026-06-05
PREZZO DELLE AZIONI
SecurityDE:5EA / Elanco Animal Health Incorporated
InstitutionStifel Financial Corp
Latest Disclosed Ownership316,761 shares
Latest Disclosed Value $ 7,580,088
Stifel Financial Corp reports 57.38% increase in ownership of 5EA / Elanco Animal Health Incorporated

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 316,761 shares of Elanco Animal Health Incorporated (DE:5EA) valued at $6,460,341 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 201,269 shares of Elanco Animal Health Incorporated. This represents a change in shares of 57.38% during the quarter. The current value of the position is $6,588,629 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 316,761 115,492 57.38 7,580 66.45 0.0016
2026-02-13 2025-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 201,269 -49,397 -19.71 4,555 -9.79 0.0041
2025-11-12 2025-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 250,666 -55,982 -18.26 5,048 15.30 0.0046
2025-08-14 2025-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 306,648 12,837 4.37 4,379 41.91 0.0043
2025-05-14 2025-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 293,811 65,534 28.71 3,085 11.61 0.0033
2025-02-13 2024-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 228,277 116,175 103.63 2,764 67.92 0.0029
2024-11-14 2024-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 112,102 50,637 82.38 1,647 85.78 0.0017
2024-08-13 2024-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 61,465 29,690 93.44 887 71.37 0.0010
2024-05-14 2024-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 31,775 -9,974 -23.89 517 -16.88 0.0006
2024-02-12 2023-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 41,749 -143,704 -77.49 622 -70.15 0.0008
2023-11-13 2023-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 185,453 72,814 64.64 2,084 83.94 0.0029
2023-08-14 2023-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 112,639 37,430 49.77 1,133 60.48 0.0016
2023-05-12 2023-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 75,209 9,942 15.23 707 -11.42 0.0010
2023-02-13 2022-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 65,267 -39,677 -37.81 798 -38.79 0.0012
2022-11-14 2022-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 104,944 -356,443 -77.25 1,302 -85.62 0.0021
2022-08-15 2022-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 461,387 -37,008 -7.43 9,057 -30.35 0.0142
2022-05-13 2022-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 498,395 432 0.09 13,004 -7.98 0.0177
2022-02-14 2021-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 497,963 63,652 14.66 14,131 2.02 0.0187
2021-11-15 2021-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 434,311 30,996 7.69 13,851 -0.99 0.0203
2021-08-13 2021-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 403,315 59,077 17.16 13,990 38.01 0.0209
2021-05-14 2021-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 344,238 -31,292 -8.33 10,137 -11.99 0.0167
2021-02-12 2020-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 375,530 116,150 44.78 11,518 59.00 0.0206
2020-11-16 2020-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 259,380 23,001 9.73 7,244 42.88 0.0149
2020-08-14 2020-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 236,379 11,978 5.34 5,070 1.16 0.0117
2020-05-14 2020-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 224,401 10,623 4.97 5,012 -20.72 0.0138
2020-02-13 2019-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 213,778 23,498 12.35 6,322 25.51 0.0132
2019-11-19 2019-09-30 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 190,280 21,438 12.70 5,037 -11.34 0.0129
2019-11-13 2019-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 190,672 21,830 5,048 2,829.6570
2019-08-14 2019-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 168,842 19,825 13.30 5,681 19.20 0.0146
2019-05-14 2019-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 149,017 49,223 49.32 4,766 51.78 0.0135
2019-02-13 2018-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 99,794 2,808 2.90 3,140 -7.07 0.0102
2018-11-13 2018-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 96,986 96,986 3,379 0.0097
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.